Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma

Irradiation and temozolomide (TMZ) chemotherapy are the current standard treatments for glioblastoma multiforme (GBM), but they are associated with toxicity and limited efficacy. Recently, these standard therapies have been used to enhance immunotherapy against GBM. Immunotherapy using the anti-CD47...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Innate Immun
Principais autores: Gholamin, Sharareh, Youssef, Osama A, Rafat, Marjan, Esparza, Rogelio, Kahn, Suzana, Shahin, Maryam, Giaccia, Amato J, Graves, Edward E, Weissman, Irving, Mitra, Siddhartha, Cheshier, Samuel H
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016411/
https://ncbi.nlm.nih.gov/pubmed/31547758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753425919876690
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados